Warsaw
Poland
6
2024-01-25
6
2025-06-03
These are the the leading inventors for applications assigned to Molecure S.A.:
Molecure S.A. based in Warsaw, PL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine
#2 | 2023-09-07 ✅ Patent 12,325,701 granted on 2025-06-10YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS
#3 | 2023-07-13 ✅ Patent 12,404,279 granted on 2025-09-02DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF
#4 | 2022-06-30 ✅ Patent 12,612,420 granted on 2026-04-28ARGINASE INHIBITORS AND METHODS OF USE THEREOF
#5 | 2021-05-20 ✅ Patent 11,746,107 granted on 2023-09-05Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine
#6 | 2021-01-21 ✅ Patent 11,638,707 granted on 2023-05-02Substituted amino triazoles useful as chitinase inhibitors
Also check out Molecure S.A.'s (Warsaw, Poland) applicant profile with 8 patent applications submitted.
598667 ⎘